Early Therapy [topp]
Autologous Stem Cell Transplantation [topp]
High Risk [qlco]
Hodgkin Disease [neop]
Long-term Follow-up [hlca]
Cases [ftcn]
Five [qnco]
Adult [aggp]
Patients [podg]
High Risk [qlco]
Defined [cnce]
Stage IV [inpr]
Bulky Disease [fndg]
Nodal [spco]
Thorax [blor]
Ratio [qnco]
partial response [fndg]
Initial [tmco]
Courses [tmco]
VD [dsyn]
Received [qlco]
Early Therapy [topp]
Autologous Stem Cell Transplantation [topp]
Patients [podg]
considered [idcn]
Partial [qnco]
Refractory [ftcn]
Initial [tmco]
Chemotherapy [topp]
conditioning regimen [topp]
Chemotherapy [topp]
Alone [qnco]
CBV [topp]
Ii [aapp]
Patients [podg]
BEAM [topp]
Patients [podg]
Radiotherapy, Adjuvant [topp]
GY [geoa]
Initial [tmco]
Sites [spco]
Bulky Disease [fndg]
GY [geoa]
Total Body Irradiation [topp]
Plus [qlco]
mg kg [qnco]
Cyclophosphamide [opco, phsu]
Patients [podg]
Disseminated [spco]
Nodal [spco]
Patients [podg]
partial response [fndg]
Autologous Stem Cell Transplantation [topp]
experience [menp]
Prolonged [tmco]
Complete Remission [fndg]
Died [orgf]
Complete Remission [fndg]
Acute myocardial infarction [dsyn]
months [tmco]
Autologous Stem Cell Transplantation [topp]
Patients [podg]
Refractory Disease [fndg]
Autologous Stem Cell Transplantation [topp]
experience [menp]
Rapid progression [fndg]
Leading [tmco]
Cases [ftcn]
Complete Remission [fndg]
Post [tmco]
Autologous Stem Cell Transplantation [topp]
Last [qlco]
Refractory [ftcn]
Died [orgf]
Myelodysplastic syndrome [neop]
Diagnosed [fndg]
therapy [ftcn]
SURVIVE [phsu]
Patients [podg]
months [tmco]
Range [qnco]
Cumulative [qlco]
Probability [qnco]
Survival [acty]
Entire [qnco]
Group [idcn]
Patients [podg]
Chemosensitivity [fndg]
Primary Refractory [fndg]
P NOS [aapp, imft]
Cumulative [qlco]
Probability [qnco]
Event-Free Survival [qnco]
Entire [qnco]
Group [idcn]
Patients [podg]
Chemosensitivity [fndg]
Primary Refractory [fndg]
P NOS [aapp, imft]
conclude [bodm, orch]
Early Therapy [topp]
Autologous Stem Cell Transplantation [topp]
Patients [podg]
High Risk [qlco]
Cure [cnce]
Chemosensitivity [fndg]
Patients [podg]
Primary Refractory [fndg]
Patients [podg]
Therapeutic [topp]
Approaches [spco]
